- ￥2508
- BioLegend-HK
- 359907
- 美国
- 2025年07月10日
- 免疫荧光，流式
- 小鼠
- 人
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 抗体名：
PerCP/Cyanine5.5 anti-human CD309 (VEGFR2)
- 抗体英文名：
PerCP/Cyanine5.5 anti-human CD309 (VEGFR2)
- 应用范围：
免疫荧光，流式
- 宿主：
小鼠
- 供应商：
上海善然生物
- 库存：
4-5周
- 抗原来源：
小鼠
- 保质期：
2-3年左右
- 适应物种：
人
- 标记物：
PerCP/Cyanine5.5
- 克隆性：
单克隆
- 保存条件：
2-8度
- 形态：
液体
- 规格：
25 tests
PerCP/Cyanine5.5 anti-human CD309 (VEGFR2) Antibody
7D4-6
Catalog# / Size 359907 / 25 tests
359908 / 100 tests
Clone
Regulatory Status RUO
Other Names KDR, Vascular Endothelial Receptor 2 (VEGF-R2, VEGFR2, VEGFR)
Isotype Mouse IgG1, κ
Description CD309, also known as VEGF-R2, KDR, and Flk-1 (mouse), is a type I transmembrane
glycoprotein. It is a member of the CSF-1/PDGF receptor family of type III tyrosine kinase
receptors. Human VEGF-R2 is mainly expressed by endothelial cells, embryonic tissues, and
megakaryocytes. It plays an important role in the regulation of angiogenesis, vasculogenesis,
and vascular permeability. The ligands of VEGF-R2 include VEGF-A, VEGF-C, and VEGF-D
splice isoforms. Activation of VEGF-R2 with its ligands results in the receptor dimerization and
autophosphorylation, stimulating endothelial cell proliferation and migration.
Product Details
Verified Reactivity Human
Antibody Type Monoclonal
Host Species Mouse
Immunogen Human KDR recombinant protein
Formulation Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
Preparation The antibody was purified by affinity chromatography and conjugated with PerCP/Cyanine5.5
under optimal conditions.
Concentration Lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our
Certificate of Analysis online tool.)
Storage & Handling The antibody solution should be stored undiluted between 2°C and 8°C, and protected from
prolonged exposure to light. Do not freeze.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验更多产品详细信息欢迎来电咨询~周祥15900853496微信同号，汪海洋15901695283微信同号
Purification of Immature CD4+CD8+ Thymocytes by Panning with Anti-CD8 Antibody
Most T lymphocytes of the immune system differentiate within the thymus along the CD4/CD8 developmental pathway by a highly ordered process termed thymic selection ( 1 , 2 ). The maturation status of thymocytes is commonly assessed
Anti-CD22 Onconase: Preparation and Characterization
Antibodies can be conjugated to effector molecules to derive targeted therapeutics with properties such as cell-specific cytotoxicity. The murine anti-CD22 antibody RFB4 linked to a member of the ribonuclease A superfamily, Onconase (Onc
分别利用 CD3 与 CD28 的功能学抗体，以及 CD3/CD28 Streptamer® 激活扩增 T 细胞的实验步骤与实验结果。 CD3/CD28抗体法 1、实验步骤： 1.1 抗体包被 用无菌 PBS 将 anti-mouse CD3 抗体（克隆号：145-2C11）稀释至 5μg/ml，稀释后的抗体加入到 24 孔板中，每孔 400μl，4°C 包被过夜。（注：板子在加入抗体之前，先用无菌 PBS 润洗 2-3 遍，避免干孔）； 1.2 小鼠脾脏淋巴细胞分离（次日） 1. 将 70μm
技术资料暂无技术资料 索取技术资料
